In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-02-28

AUTHORS

Serena Bonin, Danae Pracella, Renzo Barbazza, Sandro Sulfaro, Giorgio Stanta

ABSTRACT

Axillary lymph node status is one of the most important prognostic variables for breast cancer (BC). To investigate and understand the clinical, histopathological and biological factors that affect prognosis in node-positive young breast cancer patients, we compared the phenotype of 100 primary tumours with their corresponding loco-regional lymph node (LN) metastases using conventional immunohistochemistry (IHC) markers currently in use for molecular classification of breast cancer. By comparing the expression of ER, PR, HER-2, Ki67, K8, K5/6 and vimentin, we found that expression of HER-2, Ki67, K8 and vimentin is frequently lost in lymph node metastases. Between the primary tumour and corresponding lymph node metastases, expression of keratins K8 and K5/6 significantly changed. Expression of K8 in lymph node metastases, but not in primary tumours, segregates patients in two sub-groups with different outcomes. Survival of patients with K8-positive LN metastases at 5 years in comparison with patients with K8-negative LN metastases was 75 vs 48 %, at 10 years 62 vs 22 % and at 20 years 53 vs 14 % (p < 0.001). K8 immunostaining of tissue from the lymph node metastasis allows defining a sub-group of lymph node-positive BC patients with a highly unfavourable outcome, for whom therapeutic options might have to be reconsidered. More... »

PAGES

571-580

References to SciGraph publications

  • 2010-08-14. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-11-25. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases - aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial in BMC CANCER
  • 2008-02-14. Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families in BREAST CANCER RESEARCH
  • 2010-01-06. Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2013-03-09. Metronomic chemotherapy for cancer treatment: a decade of clinical studies in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-03-02. Stem cell-related markers in primary breast cancers and associated metastatic lesions in MODERN PATHOLOGY
  • 2005-01. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node in CLINICAL AND TRANSLATIONAL ONCOLOGY
  • 2010-03-06. Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer? in WORLD JOURNAL OF SURGERY
  • 2013-12-05. Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis in MEDICAL ONCOLOGY
  • 2014-09-11. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? in BREAST CANCER RESEARCH AND TREATMENT
  • 2009-10-21. Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness in MOLECULAR CANCER
  • 2007-06-07. Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications in VIRCHOWS ARCHIV
  • 2011-05-19. Rapid Protein Extraction from Formalin-Fixed Paraffin-Embedded Tissue Samples in GUIDELINES FOR MOLECULAR ANALYSIS IN ARCHIVE TISSUES
  • 2013-12-11. Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer in MEDICAL ONCOLOGY
  • 2010-09-16. Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer in MEDICAL ONCOLOGY
  • 2006-03. New trends of immunohistochemistry for making differential diagnosis of breast lesions in MEDICAL MOLECULAR MORPHOLOGY
  • 2012-08-01. Keratin expression in breast cancers in VIRCHOWS ARCHIV
  • 2009-08-20. Does vimentin help to delineate the so-called 'basal type breast cancer'? in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2012-11-19. Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00428-015-1748-1

    DOI

    http://dx.doi.org/10.1007/s00428-015-1748-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1026756082

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/25724181


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunohistochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Keratin-8", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphatic Metastasis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Staging", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proportional Hazards Models", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tissue Array Analysis", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bonin", 
            "givenName": "Serena", 
            "id": "sg:person.01125307154.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125307154.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pracella", 
            "givenName": "Danae", 
            "id": "sg:person.01207462724.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207462724.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Barbazza", 
            "givenName": "Renzo", 
            "id": "sg:person.0603512365.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603512365.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Laboratory Medicine, S.C. Pathology, Santa Maria degli Angeli Hospital, 33170, Pordenone, Italy", 
              "id": "http://www.grid.ac/institutes/grid.415199.1", 
              "name": [
                "Department of Laboratory Medicine, S.C. Pathology, Santa Maria degli Angeli Hospital, 33170, Pordenone, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sulfaro", 
            "givenName": "Sandro", 
            "id": "sg:person.01207513565.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207513565.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Stanta", 
            "givenName": "Giorgio", 
            "id": "sg:person.0111107245.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0111107245.10"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10549-014-3125-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009528638", 
              "https://doi.org/10.1007/s10549-014-3125-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-010-1113-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044008565", 
              "https://doi.org/10.1007/s10549-010-1113-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00428-007-0435-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014094832", 
              "https://doi.org/10.1007/s00428-007-0435-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12032-010-9676-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014769318", 
              "https://doi.org/10.1007/s12032-010-9676-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/modpathol.2012.37", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009456656", 
              "https://doi.org/10.1038/modpathol.2012.37"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12032-013-0801-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021350530", 
              "https://doi.org/10.1007/s12032-013-0801-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12032-013-0798-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001424934", 
              "https://doi.org/10.1007/s12032-013-0798-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-13-558", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047114795", 
              "https://doi.org/10.1186/1471-2407-13-558"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00268-010-0499-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009529309", 
              "https://doi.org/10.1007/s00268-010-0499-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02710021", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011714585", 
              "https://doi.org/10.1007/bf02710021"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00428-012-1289-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033437196", 
              "https://doi.org/10.1007/s00428-012-1289-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2009.230", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011430625", 
              "https://doi.org/10.1038/ejhg.2009.230"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-8-88", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038455624", 
              "https://doi.org/10.1186/1476-4598-8-88"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1756-9966-28-118", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004957771", 
              "https://doi.org/10.1186/1756-9966-28-118"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-013-2125-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048027899", 
              "https://doi.org/10.1007/s00280-013-2125-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1479-5876-10-226", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018030630", 
              "https://doi.org/10.1186/1479-5876-10-226"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr1863", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028053059", 
              "https://doi.org/10.1186/bcr1863"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00795-006-0309-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051656319", 
              "https://doi.org/10.1007/s00795-006-0309-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-642-17890-0_38", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047873716", 
              "https://doi.org/10.1007/978-3-642-17890-0_38"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-02-28", 
        "datePublishedReg": "2015-02-28", 
        "description": "Axillary lymph node status is one of the most important prognostic variables for breast cancer (BC). To investigate and understand the clinical, histopathological and biological factors that affect prognosis in node-positive young breast cancer patients, we compared the phenotype of 100 primary tumours with their corresponding loco-regional lymph node (LN) metastases using conventional immunohistochemistry (IHC) markers currently in use for molecular classification of breast cancer. By comparing the expression of ER, PR, HER-2, Ki67, K8, K5/6 and vimentin, we found that expression of HER-2, Ki67, K8 and vimentin is frequently lost in lymph node metastases. Between the primary tumour and corresponding lymph node metastases, expression of keratins K8 and K5/6 significantly changed. Expression of K8 in lymph node metastases, but not in primary tumours, segregates patients in two sub-groups with different outcomes. Survival of patients with K8-positive LN metastases at 5\u00a0years in comparison with patients with K8-negative LN metastases was 75 vs 48\u00a0%, at 10\u00a0years 62 vs 22\u00a0% and at 20\u00a0years 53 vs 14\u00a0% (p\u2009<\u20090.001). K8 immunostaining of tissue from the lymph node metastasis allows defining a sub-group of lymph node-positive BC patients with a highly unfavourable outcome, for whom therapeutic options might have to be reconsidered.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00428-015-1748-1", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1106235", 
            "issn": [
              "0945-6317", 
              "1432-2307"
            ], 
            "name": "Virchows Archiv", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "466"
          }
        ], 
        "keywords": [
          "lymph node metastasis", 
          "breast cancer patients", 
          "node metastasis", 
          "primary tumor", 
          "breast cancer", 
          "LN metastasis", 
          "cancer patients", 
          "node-positive breast cancer patients", 
          "lymph node-positive breast cancer patients", 
          "young breast cancer patients", 
          "node-positive BC patients", 
          "corresponding lymph node metastases", 
          "loco-regional lymph node metastases", 
          "survival of patients", 
          "important prognostic variables", 
          "expression of HER-2", 
          "expression of ER", 
          "years of age", 
          "lymph node-positive BC patients", 
          "years 62", 
          "axillary lymph", 
          "expression of K8", 
          "unfavourable outcome", 
          "therapeutic options", 
          "BC patients", 
          "prognostic variables", 
          "better survival", 
          "patients", 
          "immunohistochemistry markers", 
          "metastasis", 
          "keratin 8 expression", 
          "lymph", 
          "tumors", 
          "years 53", 
          "molecular classification", 
          "HER-2", 
          "Ki67", 
          "cancer", 
          "vimentin", 
          "survival", 
          "outcomes", 
          "K5/6", 
          "different outcomes", 
          "expression", 
          "keratin K8", 
          "biological factors", 
          "prognosis", 
          "years", 
          "K8", 
          "age", 
          "markers", 
          "tissue", 
          "status", 
          "phenotype", 
          "options", 
          "factors", 
          "ER", 
          "use", 
          "indicators", 
          "PR", 
          "variables", 
          "classification", 
          "comparison", 
          "node-positive young breast cancer patients", 
          "corresponding loco-regional lymph node (LN) metastases", 
          "conventional immunohistochemistry (IHC) markers", 
          "K8-positive LN metastases", 
          "K8-negative LN metastases", 
          "stage II/III lymph node-positive breast cancer patients", 
          "II/III lymph node-positive breast cancer patients", 
          "III lymph node-positive breast cancer patients"
        ], 
        "name": "In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival", 
        "pagination": "571-580", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1026756082"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00428-015-1748-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "25724181"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00428-015-1748-1", 
          "https://app.dimensions.ai/details/publication/pub.1026756082"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:35", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_683.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00428-015-1748-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00428-015-1748-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00428-015-1748-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00428-015-1748-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00428-015-1748-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    296 TRIPLES      22 PREDICATES      130 URIs      103 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00428-015-1748-1 schema:about N10c943b2170a44d6b5627d557961b57e
    2 N24da7800fcdb4a04b0fd6e9a3f417edd
    3 N26afb0291e974248a2defc3305fad084
    4 N285c99e0adcb4e43bfe43ae22f041b51
    5 N396d606f570646678176eb2b2f3b2d45
    6 N3c9c59796b14443ea7116fce22bc9792
    7 N3f7d35798ef14895a2a989368f34cfd5
    8 N479edefe548d42bb822c7fe64d90390a
    9 N6baff39463dc4445b866882f75835d33
    10 Nac816d6624414ebd8c4fb4e633c61e7b
    11 Nae000b9b0b1c48a2ae899c5ddcb0120c
    12 Nc1c8647f522f4aea88452c85ed358b88
    13 Nf1acdd14549e4e359242ce4c9e3e201b
    14 Nf6e036b92ad243018ebaf96809412ebc
    15 anzsrc-for:11
    16 anzsrc-for:1112
    17 schema:author N32e2a2ac195e4e10abdc8826de2cbe41
    18 schema:citation sg:pub.10.1007/978-3-642-17890-0_38
    19 sg:pub.10.1007/bf02710021
    20 sg:pub.10.1007/s00268-010-0499-z
    21 sg:pub.10.1007/s00280-013-2125-x
    22 sg:pub.10.1007/s00428-007-0435-2
    23 sg:pub.10.1007/s00428-012-1289-9
    24 sg:pub.10.1007/s00795-006-0309-8
    25 sg:pub.10.1007/s10549-010-1113-7
    26 sg:pub.10.1007/s10549-014-3125-1
    27 sg:pub.10.1007/s12032-010-9676-z
    28 sg:pub.10.1007/s12032-013-0798-y
    29 sg:pub.10.1007/s12032-013-0801-7
    30 sg:pub.10.1038/ejhg.2009.230
    31 sg:pub.10.1038/modpathol.2012.37
    32 sg:pub.10.1186/1471-2407-13-558
    33 sg:pub.10.1186/1476-4598-8-88
    34 sg:pub.10.1186/1479-5876-10-226
    35 sg:pub.10.1186/1756-9966-28-118
    36 sg:pub.10.1186/bcr1863
    37 schema:datePublished 2015-02-28
    38 schema:datePublishedReg 2015-02-28
    39 schema:description Axillary lymph node status is one of the most important prognostic variables for breast cancer (BC). To investigate and understand the clinical, histopathological and biological factors that affect prognosis in node-positive young breast cancer patients, we compared the phenotype of 100 primary tumours with their corresponding loco-regional lymph node (LN) metastases using conventional immunohistochemistry (IHC) markers currently in use for molecular classification of breast cancer. By comparing the expression of ER, PR, HER-2, Ki67, K8, K5/6 and vimentin, we found that expression of HER-2, Ki67, K8 and vimentin is frequently lost in lymph node metastases. Between the primary tumour and corresponding lymph node metastases, expression of keratins K8 and K5/6 significantly changed. Expression of K8 in lymph node metastases, but not in primary tumours, segregates patients in two sub-groups with different outcomes. Survival of patients with K8-positive LN metastases at 5 years in comparison with patients with K8-negative LN metastases was 75 vs 48 %, at 10 years 62 vs 22 % and at 20 years 53 vs 14 % (p < 0.001). K8 immunostaining of tissue from the lymph node metastasis allows defining a sub-group of lymph node-positive BC patients with a highly unfavourable outcome, for whom therapeutic options might have to be reconsidered.
    40 schema:genre article
    41 schema:inLanguage en
    42 schema:isAccessibleForFree false
    43 schema:isPartOf N3e05e0ea229049b5941b43bd9c24ae54
    44 Nea3aa2e575c1467f8ea12308c04cbc6a
    45 sg:journal.1106235
    46 schema:keywords BC patients
    47 ER
    48 HER-2
    49 II/III lymph node-positive breast cancer patients
    50 III lymph node-positive breast cancer patients
    51 K5/6
    52 K8
    53 K8-negative LN metastases
    54 K8-positive LN metastases
    55 Ki67
    56 LN metastasis
    57 PR
    58 age
    59 axillary lymph
    60 better survival
    61 biological factors
    62 breast cancer
    63 breast cancer patients
    64 cancer
    65 cancer patients
    66 classification
    67 comparison
    68 conventional immunohistochemistry (IHC) markers
    69 corresponding loco-regional lymph node (LN) metastases
    70 corresponding lymph node metastases
    71 different outcomes
    72 expression
    73 expression of ER
    74 expression of HER-2
    75 expression of K8
    76 factors
    77 immunohistochemistry markers
    78 important prognostic variables
    79 indicators
    80 keratin 8 expression
    81 keratin K8
    82 loco-regional lymph node metastases
    83 lymph
    84 lymph node metastasis
    85 lymph node-positive BC patients
    86 lymph node-positive breast cancer patients
    87 markers
    88 metastasis
    89 molecular classification
    90 node metastasis
    91 node-positive BC patients
    92 node-positive breast cancer patients
    93 node-positive young breast cancer patients
    94 options
    95 outcomes
    96 patients
    97 phenotype
    98 primary tumor
    99 prognosis
    100 prognostic variables
    101 stage II/III lymph node-positive breast cancer patients
    102 status
    103 survival
    104 survival of patients
    105 therapeutic options
    106 tissue
    107 tumors
    108 unfavourable outcome
    109 use
    110 variables
    111 vimentin
    112 years
    113 years 53
    114 years 62
    115 years of age
    116 young breast cancer patients
    117 schema:name In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival
    118 schema:pagination 571-580
    119 schema:productId Na5203ad1da9148a0a1a2b01e37de1c6b
    120 Nbecf113df20e470a82a5cc323b22d991
    121 Nda80afeb31bd4e5db44f2146deb86099
    122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026756082
    123 https://doi.org/10.1007/s00428-015-1748-1
    124 schema:sdDatePublished 2021-12-01T19:35
    125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    126 schema:sdPublisher Nf968c901833c4615b69d233aa620ff88
    127 schema:url https://doi.org/10.1007/s00428-015-1748-1
    128 sgo:license sg:explorer/license/
    129 sgo:sdDataset articles
    130 rdf:type schema:ScholarlyArticle
    131 N10c943b2170a44d6b5627d557961b57e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Kaplan-Meier Estimate
    133 rdf:type schema:DefinedTerm
    134 N1156e67dad9c46f184afa64eaa3b318f rdf:first sg:person.01207513565.38
    135 rdf:rest Ne979f83665cd4779a0e6852254d688e3
    136 N24da7800fcdb4a04b0fd6e9a3f417edd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Middle Aged
    138 rdf:type schema:DefinedTerm
    139 N26afb0291e974248a2defc3305fad084 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Tissue Array Analysis
    141 rdf:type schema:DefinedTerm
    142 N285c99e0adcb4e43bfe43ae22f041b51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Neoplasm Staging
    144 rdf:type schema:DefinedTerm
    145 N32e2a2ac195e4e10abdc8826de2cbe41 rdf:first sg:person.01125307154.15
    146 rdf:rest N62f5186f2ea542a58550bb193a07530c
    147 N396d606f570646678176eb2b2f3b2d45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Prognosis
    149 rdf:type schema:DefinedTerm
    150 N3c9c59796b14443ea7116fce22bc9792 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Breast Neoplasms
    152 rdf:type schema:DefinedTerm
    153 N3e05e0ea229049b5941b43bd9c24ae54 schema:volumeNumber 466
    154 rdf:type schema:PublicationVolume
    155 N3f7d35798ef14895a2a989368f34cfd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Adult
    157 rdf:type schema:DefinedTerm
    158 N479edefe548d42bb822c7fe64d90390a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Biomarkers, Tumor
    160 rdf:type schema:DefinedTerm
    161 N62f5186f2ea542a58550bb193a07530c rdf:first sg:person.01207462724.07
    162 rdf:rest Nae4f8725238347f8a1ed43145759f568
    163 N6baff39463dc4445b866882f75835d33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Proportional Hazards Models
    165 rdf:type schema:DefinedTerm
    166 Na5203ad1da9148a0a1a2b01e37de1c6b schema:name dimensions_id
    167 schema:value pub.1026756082
    168 rdf:type schema:PropertyValue
    169 Nac816d6624414ebd8c4fb4e633c61e7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Female
    171 rdf:type schema:DefinedTerm
    172 Nae000b9b0b1c48a2ae899c5ddcb0120c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Immunohistochemistry
    174 rdf:type schema:DefinedTerm
    175 Nae4f8725238347f8a1ed43145759f568 rdf:first sg:person.0603512365.60
    176 rdf:rest N1156e67dad9c46f184afa64eaa3b318f
    177 Nbecf113df20e470a82a5cc323b22d991 schema:name doi
    178 schema:value 10.1007/s00428-015-1748-1
    179 rdf:type schema:PropertyValue
    180 Nc1c8647f522f4aea88452c85ed358b88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Lymphatic Metastasis
    182 rdf:type schema:DefinedTerm
    183 Nda80afeb31bd4e5db44f2146deb86099 schema:name pubmed_id
    184 schema:value 25724181
    185 rdf:type schema:PropertyValue
    186 Ne979f83665cd4779a0e6852254d688e3 rdf:first sg:person.0111107245.10
    187 rdf:rest rdf:nil
    188 Nea3aa2e575c1467f8ea12308c04cbc6a schema:issueNumber 5
    189 rdf:type schema:PublicationIssue
    190 Nf1acdd14549e4e359242ce4c9e3e201b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Keratin-8
    192 rdf:type schema:DefinedTerm
    193 Nf6e036b92ad243018ebaf96809412ebc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Humans
    195 rdf:type schema:DefinedTerm
    196 Nf968c901833c4615b69d233aa620ff88 schema:name Springer Nature - SN SciGraph project
    197 rdf:type schema:Organization
    198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    199 schema:name Medical and Health Sciences
    200 rdf:type schema:DefinedTerm
    201 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    202 schema:name Oncology and Carcinogenesis
    203 rdf:type schema:DefinedTerm
    204 sg:journal.1106235 schema:issn 0945-6317
    205 1432-2307
    206 schema:name Virchows Archiv
    207 schema:publisher Springer Nature
    208 rdf:type schema:Periodical
    209 sg:person.0111107245.10 schema:affiliation grid-institutes:None
    210 schema:familyName Stanta
    211 schema:givenName Giorgio
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0111107245.10
    213 rdf:type schema:Person
    214 sg:person.01125307154.15 schema:affiliation grid-institutes:None
    215 schema:familyName Bonin
    216 schema:givenName Serena
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125307154.15
    218 rdf:type schema:Person
    219 sg:person.01207462724.07 schema:affiliation grid-institutes:None
    220 schema:familyName Pracella
    221 schema:givenName Danae
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207462724.07
    223 rdf:type schema:Person
    224 sg:person.01207513565.38 schema:affiliation grid-institutes:grid.415199.1
    225 schema:familyName Sulfaro
    226 schema:givenName Sandro
    227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207513565.38
    228 rdf:type schema:Person
    229 sg:person.0603512365.60 schema:affiliation grid-institutes:None
    230 schema:familyName Barbazza
    231 schema:givenName Renzo
    232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603512365.60
    233 rdf:type schema:Person
    234 sg:pub.10.1007/978-3-642-17890-0_38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047873716
    235 https://doi.org/10.1007/978-3-642-17890-0_38
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1007/bf02710021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011714585
    238 https://doi.org/10.1007/bf02710021
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1007/s00268-010-0499-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1009529309
    241 https://doi.org/10.1007/s00268-010-0499-z
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1007/s00280-013-2125-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1048027899
    244 https://doi.org/10.1007/s00280-013-2125-x
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1007/s00428-007-0435-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014094832
    247 https://doi.org/10.1007/s00428-007-0435-2
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1007/s00428-012-1289-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033437196
    250 https://doi.org/10.1007/s00428-012-1289-9
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1007/s00795-006-0309-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051656319
    253 https://doi.org/10.1007/s00795-006-0309-8
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1007/s10549-010-1113-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044008565
    256 https://doi.org/10.1007/s10549-010-1113-7
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1007/s10549-014-3125-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009528638
    259 https://doi.org/10.1007/s10549-014-3125-1
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1007/s12032-010-9676-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1014769318
    262 https://doi.org/10.1007/s12032-010-9676-z
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1007/s12032-013-0798-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1001424934
    265 https://doi.org/10.1007/s12032-013-0798-y
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1007/s12032-013-0801-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021350530
    268 https://doi.org/10.1007/s12032-013-0801-7
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1038/ejhg.2009.230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011430625
    271 https://doi.org/10.1038/ejhg.2009.230
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1038/modpathol.2012.37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009456656
    274 https://doi.org/10.1038/modpathol.2012.37
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1186/1471-2407-13-558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047114795
    277 https://doi.org/10.1186/1471-2407-13-558
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1186/1476-4598-8-88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038455624
    280 https://doi.org/10.1186/1476-4598-8-88
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1186/1479-5876-10-226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018030630
    283 https://doi.org/10.1186/1479-5876-10-226
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1186/1756-9966-28-118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004957771
    286 https://doi.org/10.1186/1756-9966-28-118
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1186/bcr1863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028053059
    289 https://doi.org/10.1186/bcr1863
    290 rdf:type schema:CreativeWork
    291 grid-institutes:None schema:alternateName Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy
    292 schema:name Department of Medical Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume 447, Trieste, Italy
    293 rdf:type schema:Organization
    294 grid-institutes:grid.415199.1 schema:alternateName Department of Laboratory Medicine, S.C. Pathology, Santa Maria degli Angeli Hospital, 33170, Pordenone, Italy
    295 schema:name Department of Laboratory Medicine, S.C. Pathology, Santa Maria degli Angeli Hospital, 33170, Pordenone, Italy
    296 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...